Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BICO & VITK -- Ignore unavailable to you. Want to Upgrade?

To: Terry D. who wrote (2243)	1/22/1999 11:48:00 AM
From: Terry D.	Read Replies (1) \| Respond to of 2395

NEWS__let's see if this is followed up. PITTSBURGH--(BUSINESS WIRE)--Jan. 22, 1999--Biocontrol Technology, Inc. (OTCBB: BICO - news) today announced that the Diasensor®1000 noninvasive glucose sensor made its debut on national television this morning on CBS-TV's ''This Morning'' show, featured as one of several products that represent the growing area of ''painless medicine''. The Diasensor 1000 is the world's first commercially available noninvasive testing device for monitoring the blood sugar levels of diabetics. Near infrared light penetrates the patient's skin, picks up a particular pattern in the blood, and then reflects this information to the Diasensor's computer. The patient's glucose reading is then displayed. The device is completely noninvasive, uses no extra supplies, and can store a significant amount of patient data. Designed for in-home use by individual diabetic patients, the Diasensor 1000 has already received the CE Mark and is therefore available in Europe. The Company is also currently developing an internet marketing plan that will wrap the Diasensor 1000 into a diabetic home-care telehealth program utilizing the Diasensor for internet transfer of extensive patient data. biz.yahoo.com